tc-99m teboroxime (Cardiotec) Report issue

Small molecule Imaging Approved FDA Priority Review FDA
ChEMBL Drugs@FDA MeSH

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 99-technetiium
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

cardiotec | sq-30217 | tc-99m-sq-30217 | tc-99m-sq 30217 labeled | tc-99m teboroxime | tc-99m-teboroxime | technetium (99mtc) teboroxime | technetium cardiotec | technetium sq 30217 | technetium tc 99m teboroxime | technetium tc99m teboroxime | technetium tc-99m teboroxime kit | technetium teboroxime

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Diagnostic Imaging (approved 1990)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue